About OptiBiotix Health (LON:OPTI)
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company's principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is operated by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology. Its Optiscreen is a screening and optimization technology platform designed to identify microbes within the human microbiome with metabolic pathways, which can interact with human physiological processes. Its OptiBiotic is a platform technology, which generates compounds and screens them for their ability to modulate the human microbiome and its microbial end products. Its platforms are applicable across a range of other human diseases.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolLON:OPTI
CUSIPN/A
Phone+44-20-79338780
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4,282.73%
Return on Equity97.34%
Return on Assets89.66%
Miscellaneous
EmployeesN/A
Outstanding Shares78,790,000
OptiBiotix Health (LON:OPTI) Frequently Asked Questions
What is OptiBiotix Health's stock symbol?
OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI."
Who are OptiBiotix Health's key executives?
OptiBiotix Health's management team includes the folowing people:
- David Eric Evans, Co-Chairman of the Board
- Stephen O'Hara, Chief Executive Officer, Executive Director
- Christina Wood, Sales and Marketing Director
- Per Rehne, Commercial Director, Director
- Luis Gosalbez, Director of Business Development
- Richard Colin Neil Davidson CBE, Non-Executive Chairman of the Board
- Gareth Allan Barker, Non-Executive Director
- Jan Peter Fredrik Wennstrom, Non-Executive Director (Age 58)
Has OptiBiotix Health been receiving favorable news coverage?
Media headlines about OPTI stock have been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. OptiBiotix Health earned a media sentiment score of 0.11 on Accern's scale. They also assigned news articles about the company an impact score of 47.48 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of OptiBiotix Health?
Shares of OPTI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is OptiBiotix Health's stock price today?
One share of OPTI stock can currently be purchased for approximately GBX 62.15.
How big of a company is OptiBiotix Health?
OptiBiotix Health has a market capitalization of £50.89 million.
How can I contact OptiBiotix Health?
OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The company can be reached via phone at +44-20-79338780.
MarketBeat Community Rating for OptiBiotix Health (OPTI)
MarketBeat's community ratings are surveys of what our community members think about OptiBiotix Health and other stocks. Vote "Outperform" if you believe OPTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
OptiBiotix Health (LON:OPTI) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | N/A | N/A | N/A | N/A |
| Consensus Rating Score: | N/A | N/A | N/A | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
OptiBiotix Health (LON:OPTI) Consensus Price Target History
OptiBiotix Health (LON:OPTI) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 4/24/2018 | FinnCap | Reiterated Rating | Corporate | |  |
(Data available from 4/26/2016 forward)
OptiBiotix Health (LON:OPTI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
OptiBiotix Health (LON OPTI) Insider Trading and Institutional Ownership History
OptiBiotix Health (LON OPTI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/1/2018 | Neil Davidson | Insider | Buy | 165,000 | GBX 60 | £99,000 | | |
(Data available from 1/1/2013 forward)
OptiBiotix Health (LON OPTI) News Headlines
| Source: |
|
OptiBiotix Health (LON:OPTI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
OptiBiotix Health (LON OPTI) Stock Chart for Thursday, April, 26, 2018
Loading chart…
